In the spirit of Rare Disease Day, save the date! We’re excited to support our partner @nordrare.bsky.social’s 2026 #NORDSymposium. 📅 April 14–15, 2026 📍 Arlington, VA 🔗 Join us in advancing care for rare diseases: nordscience.org

Every person with a rare disease deserves access to the right care, research, and support. We are proud to stand with our partner @nordrare.bsky.social to expand access to rare disease education. Join us to create a future where no condition is too rare to matter: bit.ly/4rA6FRZ 💜✨🦓

On-site at #GU26, sharing insights on advancing first-line care in locally advanced/metastatic #urothelial #carcinoma! Developed with partners LUGPA & @bladdercancerus.bsky.social, this initiative blends clinician & patient advocacy perspectives to drive community-informed education. bit.ly/4rHAgcw

Today’s the day! We’re at #RDDNIH spotlighting how advocacy partnerships shape real-world, patient-centered education in #RareDiseases. Partnering with @nordrare.bsky.social + @rettsyndrome.bsky.social, this CME initiative brings real patient experiences into case-based learning. 🔗 bit.ly/4cen8Xp

We’re heading to #AAAAI26 to join the global community advancing care in #asthma, #allergy, & #immunology. Excited to connect with leaders, researchers, & partners like @aafanational.bsky.social & @nordrare.bsky.social#AAAAI26#asthma#allergy#immunology are shaping the future of patient-centered education. See you in Philly! 🌟

We’re heading to #GU26 to share insights on advancing care in la/mUC. In collaboration with LUGPA & @bladdercancerus.bsky.social, this initiative brings clinician + patient advocacy voices into a community-informed education strategy. 🔗 bit.ly/4rHlliy @ascocancer.bsky.social

The average rare-disease patient waits years for a diagnosis, often seeing multiple specialists before receiving answers. It’s time to change that. Join the Rare Disease CME Challenge with @nordrare.bsky.social to get started: bit.ly/4kVUgph

We are proud to launch the first Earn Your Stripes: Rare Disease CME Challenge exclusively in partnership with @nordrare.bsky.social improve the early identification, diagnosis, and management of rare conditions. Start earning your stripes now: bit.ly/4rDTyQ4

Now on demand: This expert-led #CME program explores modern HoFH management, including emerging LDL-C therapies and practical strategies to optimize care. Watch now: bit.ly/4cu703X#CME #HoFH #CardiologyCME #LDLCManagement #MedicalEducation

We're presenting outcomes at #GU26! Sharing new insights on advancing first-line care in la/mUC, our poster reflects a collaborative effort with LUGPA & @bladdercancerus.bsky.social, bringing together clinical & patient perspectives. Details soon: bit.ly/4kJhhvc @ascocancer.bsky.social

It’s been an energizing few days at #Alliance26, connecting with #CME partners and peers who are focused on measurable outcomes, scalable digital education, and patient-centered programming. To learn how Medlive supports outcomes-driven CME, visit 👉 tinyurl.com/42tw8cs5 @alliance4cehp.bsky.social

🌟 Poster session highlights from #Alliance26 in Atlanta where we shared our outcomes poster, featuring learnings informed by a multi-year, multi-program educational initiative with @aafanational.bsky.social. Thank you to everyone who stopped by! Read more: bit.ly/4c0r3H9 @alliance4cehp.bsky.social

Join our expert-led #CME program on HoFH management. Explore new LDL-C therapies and case-based care strategies. Register now: bit.ly/4cu703X#CME #HoFH #CardiologyCME #LDLCManagement #MedicalEducation

Explore current evidence and best practices for advanced/metastatic NSCLC in this expert-led discussion, and earn #CME. Watch now ➡️ bit.ly/3LMAI9K#CME #MedicalEducation #LungCancer #NSCLC #PrecisionOncology

We're heading to #RDDNIH to share outcomes from a #CME initiative on #RettSyndrome, highlighting patient-centered & outcomes-driven design to help close gaps in #RareDisease care. 🌟 Stay tuned for poster details & explore rare disease programs here: bit.ly/3Mq3SM3 @nordrare.bsky.social #RDDNIH#CME#RettSyndrome#RareDiseaseSF

Throwback to 1970 or #Alliance25? 👀 🕺 Excited to share that we'll be back at #Alliance26, sharing learnings from a multi-year, multi-program outcomes assessment across clinician + patient education. Read more: 🔗 bit.ly/4rzMVNY @alliance4cehp.bsky.social @aafanational.bsky.social

Only ~20% of eligible patients receive CAR T therapy. Access shouldn’t depend on zip code. On #WorldCancerDay, take steps toward change for community-based care expansion. Act now by watching the full CME program with our partners @aacicancer.bsky.social & @astct.bsky.social 👉 bit.ly/3Zx8Jhd

Kidney-sparing management in low-grade UTUC: what does 5-year follow-up show? Experts review long-term outcomes and case-based approaches to recurrence and surveillance. ▶️ Access the program today: bit.ly/4kcoJ1L #UTUC #UroOncology #KidneySparing #Urology #ClinicalPractice

AACI has partnered with @medliveofficial.bsky.social to share on-demand education on CAR T-cell therapy for non-Hodgkin lymphoma and multiple myeloma. Expert-led sessions cover referral pathways and management strategies for community practice. Watch now: bit.ly/45eV1lV

Welcome, Dr. Hans Lee, MD, to the Advisory Board! As Director of Myeloma Research at SCRI, he leads innovative work advancing new therapeutic strategies through early-phase clinical trials. 🩺 His insight will help strengthen our #PatientCentered, video-first oncology education. 🔗 bit.ly/4rpCI6R

Are you up to date on care for Multifocal Motor Neuropathy (MMN)? Join us live today at 2:00 PM ET for expert insights on diagnosis and emerging treatment options. 👉 Save your spot now: bit.ly/4c0ePy9 #MMN #Neurology #CME #MedicalEducation #ClinicalPractice

Honored to welcome Dr. Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc) to the Advisory Board. As a Professor of Medicine & an Attending Physician at @mskcancercenter.bsky.social, he brings deep expertise in hepatobiliary cancers to our #PatientCentered digital education. 👏💡 Read more 🔗 bit.ly/4q9GPD4

New on-demand #CME explores type 2 inflammation and eosinophils in COPD, with practical guidance on personalizing care and emerging biologics. Watch on demand 👉 bit.ly/4q5xTyx#CME #MedicalEducation #Pulmonology #COPD #EosinophilicCOPD #Type2Inflammation

Welcome Dr. Aaron Lisberg, MD, Assistant Professor of Clinical Medicine at UCLA, to the Medlive Advisory Board. 👏 A leader in #immunotherapy + thoracic #oncology, he’s partnered with us since 2020 to advance clinician + patient education in #CancerCare. Read more: bit.ly/3M7wf1l

We're heading to #Alliance26 to present outcomes from our patient-centered video-first education shaped by partners like @aafanational.bsky.social Excited to join @alliance4cehp.bsky.social in celebrating 50 yrs of advancing continuing education, alongside fellow #CME leaders 🔗 bit.ly/45XLgcK

📣 We're expanding our Advisory Board! Guidance from #oncologists like Dr. Aaron Lisberg, MD, Dr. Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc), & Dr. Hans Lee, MD ensures our video-first education stays grounded in real-world needs & evolving standards of care. Full press release: prn.to/3ZpaZqO

Explore expert-led #CME on bullous pemphigoid, featuring new insights into disease biology and treatment. Now available to watch: 👉 bit.ly/49KgwOA#CME #MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies

📣 Medlive & @nordrare.bsky.social (NORD) have extended our exclusive CME partnership. We are eager to introduce innovative education models, integrate real-world data, and continue to empower the #RareDisease community. Read the full press release here: bit.ly/3YuWGka

Early diagnosis matters in C3 glomerulopathy. This #CME activity explores symptom recognition, complement pathways, and emerging therapies. 👉 Watch now: bit.ly/48TbwXO#CME #MedicalEducation #Nephrology #KidneyDisease #RareDisease #C3G #GlomerularDisease

Stay current on diagnosing and treating hypophosphatasia with expert guidance on emerging enzyme therapies and multidisciplinary care. 👉 View the on demand program: bit.ly/4sfJTQq #CME #HCPEducation #RareDiseaseEducation #Hypophosphatasia #MedicalEducation

Test your knowledge in this interactive #CME for healthcare professionals. 🩺🧠 Explore cardiovascular kidney metabolic syndrome with expert insights and real world cases. 👉 Learn more today: bit.ly/4p2uvEa#CME #MedicalEducation #Cardiology #Nephrology #Endocrinology

Boost colorectal cancer screening with evidence based strategies. 🩺 This expert led session covers guideline updates and screening options for diverse patients. 👉 Watch now and earn CME credit: bit.ly/4pJNR20 #MedicalEducation #ColorectalCancer #CancerScreening #PreventiveCare

Celebrating the gift of collaboration 🎁 ​ We’re proud to highlight Medlive’s 2025 milestone: 85 million patients impacted and counting. ​A heartfelt thank you to our 175+ organization strong partner network for their continued trust in Medlive to deliver medical education to all.​

New Alzheimer’s treatments are changing care. This #CME covers patient selection, safe initiation, side effect monitoring, and shared decision making with patients and caregivers. 🧠📚  Register now to earn CME credit: bit.ly/4qevGkN#CME #MedicalEducation #AlzheimersDisease #Neurology #DementiaCare

Learn how PTEN deficiency impacts prognosis and treatment selection, with practical insights on testing and emerging PI3K/AKT-targeted approaches. 👉 Access the program now. bit.ly/49dqZln #HCPEducation #mHSPC #ProstateCancer #Oncology #Urology 

What a week at #SABCS25! Grateful to share results from initiatives, developed in partnership with Living Beyond Breast Cancer, Surviving Breast Cancer, & Salud America. We spotlighted toxicity management, #HER2-aligned decisions & equity in #TNBC for Hispanic/Latina communities. 🔗 bit.ly/3KNajrO

New therapies, updated @kdigo.org guidance, and fresh insight into #IgAN are reshaping care.  Watch this expert program on demand anytime for practical guidance that supports stronger diagnosis and treatment. ▶️  bit.ly/4iRPqrX   

Our new on demand program breaks down how new FDA approved subcutaneous infusion therapies and emerging options are changing Parkinson’s care.  Hear practical insights and caregiver perspectives from leading experts  👉 bit.ly/4psMVPf

📣 We'll be at #SABCS25 presenting topics in #BreastCancer care:  Managing complex toxicities 👉 12/10 from 12:30–2:30 PM Advancing equity for #TNBC 👉 12/10 from 5–6:30 PM HER2 expression 👉 12/12 from 12:30–2 PM 🔗 bit.ly/3XNtrJ0#SABCS25#BreastCancer👥 Surviving Breast Cancer, Salud America, Living Beyond Breast Cancer 

Our new program on emerging therapies for SLE and lupus nephritis goes live at 1pm ET!  Don't miss it  👉 bit.ly/48vj0i3 

The RRMM landscape is shifting as earlier CAR T-cell therapy moves into focus 🔍 Watch our new on demand video for data, candidate selection, collaboration tips and guidance for managing CRS and ICANS 🎥 👉 Watch it now: bit.ly/4ijzdvr   #MultipleMyeloma #CART #Oncology

Catch our poster session at #ASH25 on 12/6 from 5:30-7:30 PM where we’ll share how, with Blood Cancer United, we've generated insights on bringing #BiospecificAntibody considerations into real-world community practice for #MultipleMyeloma patients.🩸♥️ Learn more: 🔗 bit.ly/4rEYFQe @ash.hematology.org

Stay current on the latest in food allergy care. Join us today at 2pm ET to explore new FDA approved treatments, updated care guidelines, and real patient cases. Save your spot 👉 bit.ly/4ponlLu #FoodAllergy #AllergyCare #CME #PatientSafety

Proud to stand alongside incredible partners at #SABCS25 this year, like Living Beyond Breast Cancer, Surviving Breast Cancer, & Salud America. 💗 We'll be onsite highlighting outcomes from our latest educational initiatives in #BreastCancer. Attending? Stop by! 🔗 bit.ly/4iy58Ix @sabcs.bsky.social 

🗓️ Coming soon: stay current on emerging therapies for SLE and lupus nephritis with fresh insights from leading clinicians. Register now 👉 bit.ly/3KlAHZA

The Medlive education team is heading to #ASH25 to connect with partners like Blood Cancer United who share our commitment to improving patient outcomes. Will we see you there? 👉 Read more here: bit.ly/4pT0pDZ#ASH25 #Hematology #Oncology #BloodDisorder #BloodDisorders

From empowering shared decision-making to delivering credible, accessible education, we’re committed to helping transform the way #patients and #clinicians learn across the care journey.📍Attending #ASH25? Let’s talk about what’s next for digital health education. @ash.hematology.org 

We are proud to announce our new partnership with the @pancan.bsky.social as we recognize Pancreatic Cancer Awareness Month. Learn more about the collaboration: bit.ly/48jfmYL

This Thanksgiving Week, we’re especially grateful for the providers, patients, and 175+ partners who trust Medlive to support their medical education needs.  Your dedication, insight, and trust are at the heart of everything we do.   With gratitude, The Medlive Team

Stay current on advances in #MS care. Experts share updates on diagnostic criteria, emerging biomarkers, and new clinical evidence to enhance patient-centered outcomes. Learn more 👉 bit.ly/4hVWLGp